Other specified type of carcinoma in situ of right breast
ICD-10 D05.81 is a billable code used to indicate a diagnosis of other specified type of carcinoma in situ of right breast.
Carcinoma in situ (CIS) of the breast refers to a non-invasive form of breast cancer where abnormal cells are found in the lining of the breast ducts or lobules but have not spread to surrounding tissues. The term 'other specified type' indicates that the carcinoma in situ does not fit into the more common categories, such as ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS). Patients diagnosed with D05.81 may present with various histological types of carcinoma in situ, necessitating careful surveillance and management. The risk of progression to invasive breast cancer varies based on the specific type of carcinoma in situ, with some types having a higher risk than others. Surveillance protocols typically include regular mammograms and clinical breast exams, with the frequency determined by the patient's risk factors and the specific characteristics of the carcinoma. The management may also involve surgical intervention, such as lumpectomy or mastectomy, depending on the extent of the disease and patient preferences. Understanding the nuances of this diagnosis is crucial for effective treatment planning and patient education.
Detailed pathology reports, treatment plans, and follow-up care documentation are essential.
Patients undergoing surveillance after diagnosis, treatment planning discussions, and post-operative follow-ups.
Oncologists must ensure that all documentation reflects the specific type of carcinoma in situ to avoid coding errors.
Radiology reports must clearly indicate findings related to carcinoma in situ and any imaging follow-up.
Mammograms and breast ultrasounds for surveillance of patients with a history of carcinoma in situ.
Radiologists should correlate imaging findings with pathology results to ensure accurate coding.
Used for surgical treatment of carcinoma in situ.
Operative reports must detail the procedure and findings.
Oncologists must ensure that the type of carcinoma is clearly documented in the operative report.
Carcinoma in situ is a non-invasive condition where abnormal cells are confined to the ducts or lobules of the breast, while invasive breast cancer has spread beyond these structures into surrounding breast tissue.
